These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 15582267)
1. 2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo. Rogalińska M; Błoński JZ; Hanausek M; Walaszek Z; Robak T; Kiliańska ZM Cancer Detect Prev; 2004; 28(6):433-42. PubMed ID: 15582267 [TBL] [Abstract][Full Text] [Related]
2. Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells. Kobylinska A; Blonski JZ; Hanausek M; Walaszek Z; Robak T; Kilianska ZM Oncol Rep; 2004 Mar; 11(3):699-705. PubMed ID: 14767525 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia. Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351 [TBL] [Abstract][Full Text] [Related]
4. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland. Robak T Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283 [TBL] [Abstract][Full Text] [Related]
5. Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia. Rogalinska M; Goralski P; Wozniak K; Bednarek JD; Blonski JZ; Robak T; Piekarski H; Hanausek M; Walaszek Z; Kilianska ZM Leuk Res; 2009 Feb; 33(2):308-14. PubMed ID: 18676014 [TBL] [Abstract][Full Text] [Related]
6. Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case report. Ahmad I; Al-Katib AM; Beck FW; Mohammad RM Clin Cancer Res; 2000 Apr; 6(4):1328-32. PubMed ID: 10778958 [TBL] [Abstract][Full Text] [Related]
7. Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia. Robak T; Smolewski P; Cebula B; Grzybowska-Izydorczyk O; Błoński JZ Eur J Haematol; 2007 Aug; 79(2):107-13. PubMed ID: 17635235 [TBL] [Abstract][Full Text] [Related]
8. Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group. Robak T; Blonski JZ; Wawrzyniak E; Gora-Tybor J; Palacz A; Dmoszynska A; Konopka L; Warzocha K; Jamroziak K Cancer; 2009 Jan; 115(1):94-100. PubMed ID: 19025975 [TBL] [Abstract][Full Text] [Related]
9. CDA-II, a urinary preparation, induces growth arrest and apoptosis of human leukemia cells through inactivation of nuclear factor-kappaB in a caspase-dependent manner. Huang J; Yang M; Liu H; Jin J Food Chem Toxicol; 2009 Jan; 47(1):40-9. PubMed ID: 18761050 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-2'-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB. Smal C; Lisart S; Maerevoet M; Ferrant A; Bontemps F; Van Den Neste E Biochem Pharmacol; 2007 Feb; 73(3):351-8. PubMed ID: 17137556 [TBL] [Abstract][Full Text] [Related]
11. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Bouzar AB; Boxus M; Defoiche J; Berchem G; Macallan D; Pettengell R; Willis F; Burny A; Lagneaux L; Bron D; Chatelain B; Chatelain C; Willems L Br J Haematol; 2009 Jan; 144(1):41-52. PubMed ID: 19006566 [TBL] [Abstract][Full Text] [Related]
12. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163 [TBL] [Abstract][Full Text] [Related]
13. Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia. Gora-Tybor J; Blonski JZ; Robak T Neoplasma; 2002; 49(3):145-8. PubMed ID: 12097998 [TBL] [Abstract][Full Text] [Related]
14. In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone. Kobylinska A; Bednarek J; Blonski JZ; Hanausek M; Walaszek Z; Robak T; Kilianska ZM Oncol Rep; 2006 Dec; 16(6):1389-95. PubMed ID: 17089066 [TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells. Duechler M; Linke A; Cebula B; Shehata M; Schwarzmeier JD; Robak T; Smolewski P Eur J Haematol; 2005 May; 74(5):407-17. PubMed ID: 15813915 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742 [TBL] [Abstract][Full Text] [Related]
17. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma. Robak T; Smolewski P; Cebula B; Szmigielska-Kaplon A; Chojnowski K; Blonski JZ Cancer; 2006 Oct; 107(7):1542-50. PubMed ID: 16948126 [TBL] [Abstract][Full Text] [Related]
18. Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication. Bosch F; Ferrer A; Villamor N; González M; Briones J; González-Barca E; Abella E; Gardella S; Escoda L; Pérez-Ceballos E; Asensi A; Sayas MJ; Font L; Altés A; Muntañola A; Bertazzoni P; Rozman M; Aymerich M; Giné E; Montserrat E Clin Cancer Res; 2008 Jan; 14(1):155-61. PubMed ID: 18172266 [TBL] [Abstract][Full Text] [Related]
19. Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide. Zolnierczyk JD; Błoński JZ; Robak T; Kiliańska ZM; Wesierska-Gadek J Ann N Y Acad Sci; 2009 Aug; 1171():124-31. PubMed ID: 19723046 [TBL] [Abstract][Full Text] [Related]
20. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL. Jabłońska E; Kiersnowska-Rogowska B; Rogowski F; Parfieńczyk A; Puzewska W; Bukin M Rocz Akad Med Bialymst; 2005; 50():204-7. PubMed ID: 16358967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]